Dashboard
1
With ROE of 7.91%, it has a Attractive valuation with a 0.73 Price to Book Value
- Over the past year, while the stock has generated a return of -8.17%, its profits have risen by 14% ; the PEG ratio of the company is 0.7
2
Consistent Underperformance against the benchmark over the last 3 years
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0.19%
0%
0.19%
6 Months
-1.54%
0%
-1.54%
1 Year
28.91%
0%
28.91%
2 Years
24.99%
0%
24.99%
3 Years
-18.58%
0%
-18.58%
4 Years
8.58%
0%
8.58%
5 Years
31.17%
0%
31.17%
Medipower (Overseas) PCL for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
12.79%
EBIT Growth (5y)
11.25%
EBIT to Interest (avg)
1.94
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.30
Tax Ratio
23.30%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
21.60%
ROE (avg)
6.13%
Valuation key factors
Factor
Value
P/E Ratio
9
Industry P/E
Price to Book Value
0.73
EV to EBIT
3.54
EV to EBITDA
3.54
EV to Capital Employed
0.71
EV to Sales
2.14
PEG Ratio
0.66
Dividend Yield
NA
ROCE (Latest)
20.12%
ROE (Latest)
7.91%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
36.00
35.80
0.56%
Operating Profit (PBDIT) excl Other Income
21.70
22.10
-1.81%
Interest
12.20
10.20
19.61%
Exceptional Items
-0.10
0.00
Consolidate Net Profit
32.10
8.60
273.26%
Operating Profit Margin (Excl OI)
602.50%
618.10%
-1.56%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 0.56% vs -0.28% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is 273.26% vs 115.00% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
142.70
145.00
-1.59%
Operating Profit (PBDIT) excl Other Income
85.90
87.20
-1.49%
Interest
40.30
37.50
7.47%
Exceptional Items
-1.80
-1.90
5.26%
Consolidate Net Profit
56.20
43.90
28.02%
Operating Profit Margin (Excl OI)
601.90%
601.20%
0.07%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -1.59% vs 1.68% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 28.02% vs 44.88% in Dec 2024






